BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 17714596)

  • 1. Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.
    Chin LT; Chu C; Chen HM; Hsu SC; Weng BC; Chu CH
    BMC Biotechnol; 2007 Aug; 7():51. PubMed ID: 17714596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.
    Chen PF; Freedman RS; Chernajovsky Y; Platsoucas CD
    Hum Antibodies Hybridomas; 1994; 5(3-4):131-42. PubMed ID: 7756578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The production, binding characteristics and sequence analysis of four human IgG monoclonal antiphospholipid antibodies.
    Menon S; Rahman MA; Ravirajan CT; Kandiah D; Longhurst CM; McNally T; Williams WM; Latchman DS; Isenberg DA
    J Autoimmun; 1997 Feb; 10(1):43-57. PubMed ID: 9080299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors.
    Chin LT; Malmborg AC; Kristensson K; Hinkula J; Wahren B; Borrebaeck CA
    Eur J Immunol; 1995 Mar; 25(3):657-63. PubMed ID: 7535699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis.
    Potter KN; Thomson RK; Hamblin A; Richards SD; Lindsay JG; Stevenson FK
    J Mol Biol; 2001 Feb; 306(1):37-46. PubMed ID: 11178892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
    Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
    Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel monospecific IgG2/lambda-autoantibody with specificity for a mitochondrial antigen: evidence for an antigen-driven pathogenetic B-cell response in rheumatoid synovial tissue, induced by tissue alteration.
    Krenn V; Molitoris R; Berek C; Sack U; König A; Müller-Deubert S; Kempf V; Mosgoeller W; Kerkau T; Vollmers HP; Müller-Hermelink HK
    Lab Invest; 1998 Apr; 78(4):485-96. PubMed ID: 9564893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
    Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
    Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, isolation and characterization of human tumor in situ monoclonal antibodies.
    Wu H; Pancook JD; Beuerlein G; Chilton T; Pecht G; Huse WD; Watkins JD
    Cancer Immunol Immunother; 2002 Apr; 51(2):79-90. PubMed ID: 11904732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice.
    Fishwild DM; O'Donnell SL; Bengoechea T; Hudson DV; Harding F; Bernhard SL; Jones D; Kay RM; Higgins KM; Schramm SR; Lonberg N
    Nat Biotechnol; 1996 Jul; 14(7):845-51. PubMed ID: 9631008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of single-chain Fv with two possible CDR3H conformations but similar inter-molecular forces that neutralize bovine herpesvirus 1.
    Koti M; Farrugia W; Nagy E; Ramsland PA; Kaushik AK
    Mol Immunol; 2010 Feb; 47(5):953-60. PubMed ID: 20006385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of human lambda I variable regions with a monoclonal antibody to a defined, germ-line-encoded idiotope correlates with V lambda Ia chemical structure.
    Suleyman S; Hosono O; Sioud M; Randen I; Thompson KM; Førre O; Natvig JB
    J Immunol; 1993 Jun; 150(12):5466-75. PubMed ID: 8515071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and serologic characterization of human lambda VIII light chains.
    Solomon A; Weiss DT; Murphy C; Fu SM; Robbins DL
    J Immunol; 1994 Aug; 153(4):1658-64. PubMed ID: 8046238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.
    Newman R; Hariharan K; Reff M; Anderson DR; Braslawsky G; Santoro D; Hanna N; Bugelski PJ; Brigham-Burke M; Crysler C; Gagnon RC; Dal Monte P; Doyle ML; Hensley PC; Reddy MP; Sweet RW; Truneh A
    Clin Immunol; 2001 Feb; 98(2):164-74. PubMed ID: 11161972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.
    Chin LT; Chu C; Chen HM; Wang DW; Liao SK
    Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
    Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
    J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.